Twin Capital Management Inc Incyte Corp Transaction History

Twin Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$74.18 - $108.93 $432,469 - $635,061	-5,830 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$63.18 - $85.97 $11,372 - $15,474	180 Added 3.19%	5,830 $427,000
Q4 2019 Jan 29, 2020	SELL	$73.04 - $95.72 $5,843 - $7,657	-80 Reduced 1.4%	5,650 $493,000
Q3 2019 Oct 28, 2019	BUY	$72.82 - $86.52 $417,258 - $495,759	5,730 New	5,730 $425,000

619

215M

366K

445K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Twin Capital Management Inc with notifications on news.